Literature DB >> 23822165

CXCR4 heterogeneous expression in esophageal squamous cell cancer and stronger metastatic potential with CXCR4-positive cancer cells.

C-L Lu1, J Guo, J Gu, D Ge, Y-Y Hou, Z-W Lin, J-Y Ding.   

Abstract

CXCR4 belongs to a family of G protein-coupled cell surface receptors and has been proved to a prognostic marker in a various tumors, including esophageal squamous cell cancer. In this study, we analyzed CXCR4 expression in tumor tissue and metastatic tumor tissues of lymph node by immunohistochemistry. CXCR4 was found to be an independent factor of patients' survival and heterogeneously expressed in tumor tissues. Compared with the primary tumor tissues, the scores of CXCR4 expression were significantly higher in corresponding metastatic tumor tissues of lymph nodes (P < 0.01). It was suggested CXCR4-positive cells were prone to migrate to lymph nodes. In the further experiments in vitro, we confirmed heterogeneous expression of CXCR4 in esophageal squamous cell cancer cell lines (KYSE70, Ec109, and CaES17) by flow cytometry analysis. Meanwhile, two subpopulations were isolated from Ec109 based on CXCR4 membrane expression by fluorescence-activated cell sorting. CXCR4-positive cells showed stronger migration ability in Boyden chamber assay than CXCR4 negative ones (P < 0.01). However, no significant difference of cell proliferation was found between the two subpopulations in colony formation assay (P > 0.05). We concluded that CXCR4 might be a key molecule in esophageal squamous cell cancer metastasis.
© 2013 Wiley Periodicals, Inc. and the International Society for Diseases of the Esophagus.

Entities:  

Keywords:  CXCR4; esophageal squamous cell cancer; heterogeneous expression; metastasis; migration

Mesh:

Substances:

Year:  2013        PMID: 23822165     DOI: 10.1111/dote.12100

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  17 in total

Review 1.  Can nanomedicines kill cancer stem cells?

Authors:  Yi Zhao; Daria Y Alakhova; Alexander V Kabanov
Journal:  Adv Drug Deliv Rev       Date:  2013-10-10       Impact factor: 15.470

Review 2.  Chemokines and their receptors as biomarkers in esophageal cancer.

Authors:  Masakazu Goto; Mingyao Liu
Journal:  Esophagus       Date:  2019-11-26       Impact factor: 4.230

3.  Clinicopathological and prognostic significance of chemokine receptor CXCR4 overexpression in patients with esophageal cancer: a meta-analysis.

Authors:  Jingxun Wu; Xuan Wu; Wenhua Liang; Chunling Chen; Lingling Zheng; Hanxiang An
Journal:  Tumour Biol       Date:  2013-12-11

4.  Genome-wide screening and co-expression network analysis identify recurrence-specific biomarkers of esophageal squamous cell carcinoma.

Authors:  Zong-wu Lin; Jie Gu; Rong-hua Liu; Xiao-ming Liu; Feng-kai Xu; Guang-yin Zhao; Chun-lai Lu; Di Ge
Journal:  Tumour Biol       Date:  2014-08-03

5.  Regulation of CXCR4/AKT-signaling-induced cell invasion and tumor metastasis by RhoA, Rac-1, and Cdc42 in human esophageal cancer.

Authors:  Jing Guo; Xiaofang Yu; Jie Gu; Zongwu Lin; Guangyin Zhao; Fengkai Xu; Chunlai Lu; Di Ge
Journal:  Tumour Biol       Date:  2015-12-02

Review 6.  The tumour immune microenvironment in oesophageal cancer.

Authors:  Maria Davern; Noel E Donlon; Margaret R Dunne; Robert Power; Conall Hayes; Ross King; John V Reynolds
Journal:  Br J Cancer       Date:  2021-04-26       Impact factor: 7.640

Review 7.  CXCR4 over-expression and survival in cancer: a system review and meta-analysis.

Authors:  Hongli Zhao; Liyuan Guo; Hong Zhao; Jiaxin Zhao; Hao Weng; Bin Zhao
Journal:  Oncotarget       Date:  2015-03-10

8.  Expression and function of CXCL12/CXCR4/CXCR7 in thyroid cancer.

Authors:  Xiaoli Zhu; Qianming Bai; Yongming Lu; Yiqiong Lu; Linlin Zhu; Xiaoyan Zhou; Lijing Wu
Journal:  Int J Oncol       Date:  2016-04-12       Impact factor: 5.650

9.  Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.

Authors:  Fengkai Xu; Cheng-Zhi Xu; Jie Gu; Xiaoming Liu; Ronghua Liu; Enyu Huang; Yunfeng Yuan; Guangyin Zhao; Jiahao Jiang; Chen Xu; Yiwei Chu; Chunlai Lu; Di Ge
Journal:  Oncotarget       Date:  2016-07-12

Review 10.  Esophageal cancer stem cells and implications for future therapeutics.

Authors:  Xia Qian; Cheng Tan; Feng Wang; Baixia Yang; Yangyang Ge; Zhifeng Guan; Jing Cai
Journal:  Onco Targets Ther       Date:  2016-04-19       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.